A Study of Patients Receiving Adjuvant Nivolumab Therapy for Melanoma That Has Been Removed
Clinical trial NCT03771859 · COMPLETED
Trial details
- NCT number
- NCT03771859
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-01-16
- Primary completion
- 2025-12-09
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.